AzTrials
AzTrials

Post-Op ComplicationMECH-ORLNCT05269368

Interest of Wicking for Ossicular Surgery and Myringoplasty

A study testing Wicking and No wicking in people with Post-Op Complication and Otologic Disease, run by University Hospital, Tours at 6 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-Op Complication, Otologic Disease
What is being tested?
Wicking and No wicking
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
6 sitesFrance
Study dates
16 May 2022to 16 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient (age 18 = or + ), whose mother tongue is French or who understands French language
  • Ossicular surgery (fitting of a partial or total ossicular prosthesis) or myringoplasty performed endoscopically, from the speculum, from the duct or from the endaural.
  • Tympanic reconstruction by all types of grafts: cartilage, fascia, autologous fat
  • Written consent signed by the participant
  • Affiliation to a social security scheme,

Who cannot join

  • Pregnant or breastfeeding woman, patient under legal protection, guardianship or curatorship.
  • Need for a retroauricular approach.
  • Need for annulus detachment> 60%
  • Presence of cholesteatoma or middle ear tumor

Trial locations and contacts

6 sites in 1 country.

Wiebe de JONG, MSc contact

+33247474680

w.dejong@chu-tours.fr

6 sites in 1 country

France6 sites, 5 recruiting
  • Hospital Blois

    Blois, 41000

    Charles-Edouard ROUF, MD-PhD, +33254556525, charles.rouf@outlook.com

    Recruiting
  • University Hospital BREST

    Brest, 29200

    Active, not recruiting
  • Hospital Le Mans

    Le Mans, 72037

    Catherine BOBIN, MD-PhD, +33243434325, catherinebobin@gmail.com

    Recruiting
  • University Hospital NANTES

    Nantes, 44000

    Guillaume MICHEL, MD-PhD, +33240083475, guillaume.michel@chu-nantes.fr

    Recruiting
  • Hospital La Pitié Salpêtrière-APHP

    Paris, 75013

    Daniele BERNARDESCHI, MD-PhD, +33142177440, daniele.bernardeschi@aphp.fr

    Recruiting
  • University Hospital TOURS

    Tours, 37044

    Charles AUSSEDAT, MD-PhD, +33218370523, c.aussedat@chu-tours.fr

    David BAKHOS, MD-PhD, +33218370523, Bakhos.David@gmail.com

    Recruiting

Other trials in France

About this study

Official title: Intérêt du méchage Pour la Chirurgie Ossiculaire et la Myringoplastie : Essai contrôlé randomisé Multicentrique de Non-infériorité

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Read the detailed description

Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.

Putting in place a wicking often requires to remove this wicking, feared by the patient. In addition, wicking leads to obstruction of the external acoustic meatus responsible for functional discomfort (feeling of fullness in the ear, pain, significant conductive deafness) which can last from one to several weeks depending on the type of wicking.

Despite these drawbacks, the rationale for wicking has never been established, the choice of wick type is often empirical, and its necessity is sometimes controversial in the literature. Recent studies have studied the absence of wicking as an alternative to overcome its many drawbacks. No prospective, randomized, multicenter study has been performed to show the superiority of wicking in healing following middle ear surgery (myringoplasty, stapedo-vestibular ankylosis, ossiculoplasty) via the duct or the endaural route. The only study with a high level of evidence concerns only endoscopic surgery. This study has the advantage of showing that with comparable audiometric and healing results, the absence of wicking allows a reduced operating time, an earlier reduction in otorrhea and the feeling of blocked ears, and an earlier improvement of hearing. Given this work in the literature, our hypothesis is that tympanic healing is not impaired in the absence of wicking.

Being tested
Wicking, No wicking
Keywords
Ossicular surgery, Otological surgeries, Wicking
Medical subject headings
Postoperative Complications, Ear Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WickingProcedure or surgery

    Absorbable or non-absorbable wicking

  • No wickingProcedure or surgery

    No wicking after surgery

Study groups in NCT05269368
Study groupRoleWhat they receive
No wickingExperimentalAbsence of Wicking after intervention
Receives: Procedure: No wicking
ControlActive comparatorWicking after intervention
Receives: Procedure: Wicking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tympanic and external auditory canal healing

    Healing of tympanic membrane and external auditory canal, evaluated blindly by 3 experts, on an oto-endoscopy picture.

    Measured: Three months after intervention.

Secondary outcomes (7)
  1. Audiometric results

    Audiometric results defined by the pure-tone average on 500, 1000, 2000 and 3000 Hz frequencies.

    Measured: Pre-operative, 3 months, 12 months

  2. Post-operative satisfaction

    Visual Analogic scale (0-10 (min-max))

    Measured: Immediate post-operative, day 7-10, day 30, 3 months

  3. Post-operative pain

    Visual Analogic scale (0-10 (min-max))

    Measured: Immediate post operative,day 7-10, day 30, 3 months

  4. Post-operative quality of life

    Glasgow Benefit Inventory (-100 (min) to +100 (max))

    Measured: Day 7-10, day 30, 3 months,12 months

  5. Post-operative stress

    Perceived Stress Scale (PSS-10) 10-50 (min-max) Never to often

    Measured: Pre-operative, day 7-10, day 30, 3 months, 12 months

  6. Operative time

    Operative time of the otology surgery, in minutes

    Measured: 30-120 minutes

  7. Complications

    Questionnaire given to surgeons, allowing description of complications

    Measured: At any time of the follow-up,up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2022
  2. Study start16 May 2022
  3. Primary completion16 May 2025 (estimated)
  4. Study completion16 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
* Experimental group: No Wicking * Control groupe: Wicking after intervention
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05269368
Sponsor's protocol ID
DR210132-MECH-ORL
Other IDs
2021-A02788-33, 221 A15
Acronym
MECH-ORL
Status last verified
Jul 2022
First submitted
21 Jan 2022
Last updated
6 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Wicking and No wicking in people with Post-Op Complication and Otologic Disease, run by University Hospital, Tours at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Charles AUSSEDAT, MD (+33247474747 ext. 74518, c.aussedat@chu-tours.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tympanic and external auditory canal healing (time frame: Three months after intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in